StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) stock

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.51−0.02 (-1.31%)

Close on Nov 18, 2026Market cap $1.98MP/E –Yield –

Can-Fite BioPharma net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$9.83M. The highest annual figure on record is $8.26M in fiscal 2016.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.83M–
FY2024Dec 31, 2024-$7.88M–
FY2023Dec 31, 2023-$7.63M–
FY2022Dec 31, 2022-$10.17M–
FY2021Dec 31, 2021-$12.62M–
FY2020Dec 31, 2020-$14.44M–
FY2019Dec 31, 2019-$12.63M–
FY2018Dec 31, 2018-$6.57M–
FY2017Dec 31, 2017-$4.84M-158.6%
FY2016Dec 31, 2016$8.26M+32.3%
FY2015Dec 31, 2015$6.24M–

More Can-Fite BioPharma figures

See a number that looks wrong?